Evanston, IL, United States of America

Matthew J Moschitto


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Gloucester, MA (US) (2020)
  • Evanston, IL (US) (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew J Moschitto

Introduction

Matthew J Moschitto is an accomplished inventor based in Evanston, IL (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymatic activities. With a total of two patents to his name, his work is focused on addressing critical health issues.

Latest Patents

Moschitto's latest patents include innovative compounds and methods for treating diseases associated with ornithine aminotransferase (OAT) activity. One of his notable patents is for analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid, which are designed to modulate OAT activity. These compounds have potential therapeutic applications for treating conditions such as hepatocellular carcinoma and other cancers. Another significant patent involves the synthesis of (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, along with pharmaceutical compositions containing this compound.

Career Highlights

Matthew J Moschitto is affiliated with Northwestern University, where he conducts research and develops his innovative compounds. His work is characterized by a strong focus on the synthesis and application of novel chemical entities aimed at improving health outcomes.

Collaborations

Moschitto collaborates with Richard B Silverman, a fellow researcher, to advance their shared goals in medicinal chemistry. Their partnership enhances the potential for groundbreaking discoveries in the field.

Conclusion

Matthew J Moschitto's contributions to medicinal chemistry through his patents and research at Northwestern University highlight his commitment to innovation in healthcare. His work continues to pave the way for new therapeutic options in the treatment of serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…